Roche Analytic Services has released a new report highlighting the persistent challenges in data-driven healthcare. The report, sponsored by Roche Diagnostics and conducted by Harvard Business Review Analytic Services (HBRAS), explores the impact of data and technology in healthcare over the past four years.
The report reveals that managing data across different healthcare settings remains a challenge, with 68% of survey respondents stating that their organizations use software applications or tools to consolidate data from diverse sources. In addition, more than half of the respondents prefer digital solutions that are evidence-backed and medically certified.
Corinne Dive-Reclus, Global Head for Lab Insights at Roche Diagnostics, commented on the findings, saying, These findings reflect our experiences as we help labs and hospitals worldwide use digital technologies to transform every stage of patient care, including prevention, diagnosis, treatment, and disease monitoring. In partnership with others, we take a holistic, science-based approach, offering ecosystem solutions that are inclusive to collaborators and address interoperability challenges and operational efficiencies, while helping deliver clinical insights in timely ways that aid patient care.
One notable trend highlighted in the report is the growth of collaborations and digital ecosystems in healthcare. Respondents expressed the need for partners with data analytics capabilities, digital tools, healthcare clinical experiences, artificial intelligence and machine learning expertise, cybersecurity measures, and extensive data sets for applying machine learning.
Data privacy and security also remain top concerns as more organizations adopt cloud-based solutions. The report indicates that 70% of respondents agree that data-driven healthcare introduces new risks for patient data privacy and security, while 66% agree that integrating hospital/lab operations creates new risks for the privacy and security of institutional data.
Matt Manley, Vice President, Digital Healthcare Solutions at Roche Diagnostics, highlighted the company’s approach to address these challenges. He stated, At Roche, we are using our healthcare and technology experience to build open digital ecosystems and solutions with partners to facilitate data access, maintain privacy, and address interoperability. Combined with our diverse, growing digital solution portfolio, we are helping labs and hospitals unlock new opportunities for their clinicians and patients to benefit from personalized care approaches.
The 2023 report includes insights from eight global experts and findings from a survey of 757 members of the Harvard Business Review audience. The participants, who work in healthcare or a related industry and are familiar with their organization’s use of health data and digital technologies, provided valuable input for the report. This update builds upon the 2019 report Leading a New Era in Healthcare: Innovation through Data-Driven Diagnostics.
Roche, founded in 1896, has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company is dedicated to discovering and developing medicines and diagnostics to improve and save lives worldwide. With a focus on personalized healthcare, Roche partners with various stakeholders to combine strengths in diagnostics and pharma with insights from clinical practice.
Roche’s efforts in pursuing a long-term perspective while improving access to healthcare have been recognized by the Dow Jones Sustainability Indices, consistently naming the company one of the most sustainable in the pharmaceuticals industry for the past thirteen years.
In conclusion, the new report by Roche Analytic Services sheds light on the persistent challenges faced by healthcare organizations in adopting data-driven approaches. The report emphasizes the importance of managing data across settings, fostering collaborations and digital ecosystems, and addressing data privacy and security concerns. With its ongoing commitment to innovation, Roche aims to facilitate personalized care approaches and unlock new opportunities for clinicians and patients in the digital healthcare landscape.
